v3.26.1
Balance Sheet Details (Tables)
6 Months Ended
Jun. 30, 2026
Balance Sheet Related Disclosures [Abstract]  
Schedule of Cash and Cash Equivalents

Cash, cash equivalents and restricted cash consisted of the following (in thousands):

 

 

 

June 30, 2026

 

 

December 31, 2025

 

Cash and cash equivalents

 

$

270,026

 

 

$

120,863

 

Restricted cash

 

 

2,091

 

 

 

2,433

 

Total cash, cash equivalents and restricted cash

 

$

272,117

 

 

$

123,296

 

Schedule of Accounts Receivable, Net

Accounts receivable consisted of the following (in thousands):

 

 

 

June 30, 2026

 

 

December 31, 2025

 

Trade receivables

 

$

15,973

 

 

$

13,715

 

Less: allowance for expected credit losses

 

 

(226

)

 

 

(284

)

Accounts receivable, net

 

$

15,747

 

 

$

13,431

 

Schedule of Inventories

Inventory consisted of the following (in thousands):

 

 

 

June 30, 2026

 

 

December 31, 2025

 

Raw materials

 

$

8,031

 

 

$

8,631

 

Work-in-process

 

 

322

 

 

 

253

 

Finished goods

 

 

8,750

 

 

 

11,097

 

Total inventory

 

$

17,103

 

 

$

19,981

 

Schedule of Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

 

 

 

June 30, 2026

 

 

December 31, 2025

 

Laboratory and manufacturing equipment

 

$

34,230

 

 

$

35,383

 

Leasehold improvements

 

 

13,783

 

 

 

14,050

 

Computer equipment

 

 

2,741

 

 

 

2,303

 

Internal-use software

 

 

13,096

 

 

 

13,118

 

Office furniture and fixtures

 

 

1,625

 

 

 

1,683

 

Property and equipment, gross

 

 

65,475

 

 

 

66,537

 

Less: accumulated depreciation and amortization

 

 

(50,735

)

 

 

(48,162

)

Construction-in-progress

 

 

560

 

 

 

900

 

Property and equipment, net

 

$

15,300

 

 

$

19,275

 

Accrued Liabilities

Accrued liabilities, which are included in current liabilities on the condensed consolidated balance sheets consisted of the following (in thousands):

 

 

 

June 30, 2026

 

 

December 31, 2025

 

Accrued legal fees

 

$

8,219

 

 

$

3,513

 

Accrued litigation settlement indemnification (1)

 

 

7,500

 

 

 

—

 

Accrued compensation and related benefits

 

 

6,025

 

 

 

18,146

 

Uninvoiced receipts

 

 

1,713

 

 

 

941

 

Accrued restructuring

 

 

459

 

 

 

2,916

 

Accrued warranties

 

 

497

 

 

 

683

 

Accrued taxes

 

 

3,031

 

 

 

2,133

 

Other

 

 

2,164

 

 

 

1,451

 

Accrued liabilities

 

$

29,608

 

 

$

29,783

 

(1)
Represents the Company’s indemnification obligation to Illumina related to the litigation described in Note 6, Commitments and Contingencies. The Company paid this amount in July 2026.